EU Clinical Trial Information System (CTIS)

Brand Logo

Brand Logo Light

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

The main objective of the study is to determine the proportion of patients with M + mutation status among patients with Non Small Cell Lung Cancer adenocarcinoma.

Observational study on the management of patients with Non Small Cell Lung Cancer adenocarcinoma

Research Site

Observational study on the management of patients with Non Small Cell Lung Cancer (NSCLC) adenocarcinoma tested for the activating mutation of Epidermal Growth Factor Receptor Tyrosine kinase (EGFR TK)

Observational study on the management of patients with Non Small Cell Lung Cancer adenocarcinoma - MUTACT

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=993&filename=CSR-NIS-OFR-DUM-2010-1.pdf

CSR-NIS-OFR-DUM-2010-1.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator